vs
太平洋生物科学（ASMB）与Ispire Technology Inc.（ISPR）财务数据对比。点击上方公司名可切换其他公司
Ispire Technology Inc.的季度营收约是太平洋生物科学的1.9倍（$20.3M vs $10.8M），Ispire Technology Inc.净利率更高（-32.5% vs -85.2%，领先52.7%），太平洋生物科学同比增速更快（57.6% vs -51.5%），Ispire Technology Inc.自由现金流更多（$-4.0M vs $-15.2M）
该公司是一家成立于2004年的美国生物科技企业，主要研发生产基因测序相关设备，同时也开展新型实时生物观测技术相关业务。目前拥有两大核心测序平台，分别是基于零模波导特性的单分子实时测序平台，以及结合天然核苷酸无痕连接技术的结合测序平台。
Ispire科技是一家专注于先进雾化硬件及配套耗材研发、生产与销售的全球化科技企业，主要服务尼古丁及合法大麻消费市场，下设硬件、品牌大麻产品两大核心业务板块，覆盖北美、欧洲、亚太等核心市场，为B端合作商及终端用户提供合规创新的雾化解决方案。
ASMB vs ISPR — 直观对比
营收规模更大
ISPR
是对方的1.9倍
$10.8M
营收增速更快
ASMB
高出109.1%
-51.5%
净利率更高
ISPR
高出52.7%
-85.2%
自由现金流更多
ISPR
多$11.1M
$-15.2M
损益表 — Q3 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $10.8M | $20.3M |
| 净利润 | $-9.2M | $-6.6M |
| 毛利率 | — | 17.1% |
| 营业利润率 | -100.9% | -33.9% |
| 净利率 | -85.2% | -32.5% |
| 营收同比 | 57.6% | -51.5% |
| 净利润同比 | 4.3% | 17.4% |
| 每股收益（稀释后） | $-0.72 | $-0.12 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASMBISPR
| Q4 25 | — | $20.3M | ||
| Q3 25 | $10.8M | $30.4M | ||
| Q2 25 | $9.6M | $20.1M | ||
| Q1 25 | $9.4M | $26.2M | ||
| Q4 24 | $7.4M | $41.8M | ||
| Q3 24 | $6.8M | $39.3M | ||
| Q2 24 | $8.5M | $37.3M | ||
| Q1 24 | $5.8M | $30.0M |
净利润ASMBISPR
| Q4 25 | — | $-6.6M | ||
| Q3 25 | $-9.2M | $-3.3M | ||
| Q2 25 | $-10.2M | $-14.8M | ||
| Q1 25 | $-8.8M | $-10.9M | ||
| Q4 24 | — | $-8.0M | ||
| Q3 24 | $-9.6M | $-5.6M | ||
| Q2 24 | $-11.2M | $-3.5M | ||
| Q1 24 | $-9.1M | $-5.9M |
毛利率ASMBISPR
| Q4 25 | — | 17.1% | ||
| Q3 25 | — | 17.0% | ||
| Q2 25 | — | 12.3% | ||
| Q1 25 | — | 18.2% | ||
| Q4 24 | — | 18.5% | ||
| Q3 24 | — | 19.5% | ||
| Q2 24 | — | 28.3% | ||
| Q1 24 | — | 20.4% |
营业利润率ASMBISPR
| Q4 25 | — | -33.9% | ||
| Q3 25 | -100.9% | -8.9% | ||
| Q2 25 | -115.2% | -72.7% | ||
| Q1 25 | -105.5% | -40.4% | ||
| Q4 24 | — | -17.6% | ||
| Q3 24 | -160.1% | -13.4% | ||
| Q2 24 | -143.0% | -9.2% | ||
| Q1 24 | -185.5% | -18.8% |
净利率ASMBISPR
| Q4 25 | — | -32.5% | ||
| Q3 25 | -85.2% | -10.7% | ||
| Q2 25 | -105.9% | -73.4% | ||
| Q1 25 | -93.6% | -41.5% | ||
| Q4 24 | — | -19.1% | ||
| Q3 24 | -140.4% | -14.2% | ||
| Q2 24 | -130.7% | -9.4% | ||
| Q1 24 | -156.9% | -19.7% |
每股收益（稀释后）ASMBISPR
| Q4 25 | — | $-0.12 | ||
| Q3 25 | $-0.72 | $-0.06 | ||
| Q2 25 | $-1.33 | $-0.26 | ||
| Q1 25 | $-1.17 | $-0.19 | ||
| Q4 24 | — | $-0.14 | ||
| Q3 24 | $-1.51 | $-0.10 | ||
| Q2 24 | $-1.98 | $-0.07 | ||
| Q1 24 | $-1.66 | $-0.11 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $22.5M | $17.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $182.7M | $-7.7M |
| 总资产 | $240.0M | $84.4M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ASMBISPR
| Q4 25 | — | $17.6M | ||
| Q3 25 | $22.5M | $22.7M | ||
| Q2 25 | $24.0M | $24.4M | ||
| Q1 25 | $23.4M | $23.5M | ||
| Q4 24 | $38.3M | $34.4M | ||
| Q3 24 | $28.5M | $37.7M | ||
| Q2 24 | $19.2M | $35.1M | ||
| Q1 24 | $18.7M | $39.5M |
股东权益ASMBISPR
| Q4 25 | — | $-7.7M | ||
| Q3 25 | $182.7M | $-1.8M | ||
| Q2 25 | $18.1M | $604.7K | ||
| Q1 25 | $27.1M | $14.8M | ||
| Q4 24 | $33.4M | $24.2M | ||
| Q3 24 | $26.0M | $30.7M | ||
| Q2 24 | $34.7M | $34.5M | ||
| Q1 24 | $32.6M | $35.9M |
总资产ASMBISPR
| Q4 25 | — | $84.4M | ||
| Q3 25 | $240.0M | $96.4M | ||
| Q2 25 | $80.8M | $102.2M | ||
| Q1 25 | $99.0M | $115.7M | ||
| Q4 24 | $119.2M | $132.0M | ||
| Q3 24 | $100.3M | $129.0M | ||
| Q2 24 | $115.3M | $122.6M | ||
| Q1 24 | $119.9M | $108.0M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-15.1M | $-4.0M |
| 自由现金流经营现金流 - 资本支出 | $-15.2M | $-4.0M |
| 自由现金流率自由现金流/营收 | -140.7% | -19.9% |
| 资本支出强度资本支出/营收 | 0.4% | 0.3% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-14.2M |
8季度趋势，按日历期对齐
经营现金流ASMBISPR
| Q4 25 | — | $-4.0M | ||
| Q3 25 | $-15.1M | $-1.2M | ||
| Q2 25 | $-16.8M | $4.7M | ||
| Q1 25 | $-23.4M | $-12.5M | ||
| Q4 24 | $-51.1M | $-3.2M | ||
| Q3 24 | $-15.2M | $3.6M | ||
| Q2 24 | $-17.1M | $-1.4M | ||
| Q1 24 | $-18.4M | $3.4M |
自由现金流ASMBISPR
| Q4 25 | — | $-4.0M | ||
| Q3 25 | $-15.2M | $-1.2M | ||
| Q2 25 | — | $3.7M | ||
| Q1 25 | — | $-12.7M | ||
| Q4 24 | $-51.1M | $-3.2M | ||
| Q3 24 | — | $3.3M | ||
| Q2 24 | $-17.1M | $-2.2M | ||
| Q1 24 | $-18.4M | $3.3M |
自由现金流率ASMBISPR
| Q4 25 | — | -19.9% | ||
| Q3 25 | -140.7% | -3.9% | ||
| Q2 25 | — | 18.6% | ||
| Q1 25 | — | -48.4% | ||
| Q4 24 | -695.2% | -7.7% | ||
| Q3 24 | — | 8.5% | ||
| Q2 24 | -200.6% | -5.9% | ||
| Q1 24 | -317.7% | 10.9% |
资本支出强度ASMBISPR
| Q4 25 | — | 0.3% | ||
| Q3 25 | 0.4% | 0.0% | ||
| Q2 25 | 0.0% | 4.8% | ||
| Q1 25 | 0.0% | 0.7% | ||
| Q4 24 | 0.4% | 0.1% | ||
| Q3 24 | 0.0% | 0.7% | ||
| Q2 24 | 0.2% | 2.0% | ||
| Q1 24 | 0.2% | 0.3% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
